Detalles de la búsqueda
1.
A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy Adults.
J Clin Immunol
; 44(1): 28, 2023 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38129731
2.
You can make a difference in the administration of intravenous immunoglobulin therapy.
J Infus Nurs
; 29(3 Suppl): S5-14, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16878850
3.
Practical Considerations for Self-Administration of Subcutaneous Immunoglobulin G Utilizing Recombinant Human Hyaluronidase, an Advanced Method of Subcutaneous Administration: A Nurse's Perspective.
J Infus Nurs
; 39(6): 359-368, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27828933
4.
Subcutaneous immunoglobulin-g replacement therapy with preparations currently available in the United States for intravenous or intramuscular use: reasons and regimens.
Allergy Asthma Clin Immunol
; 1(3): 120-30, 2005 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20529223
5.
Health-related quality of life of children with primary immunodeficiency disease: a comparison study.
Ann Allergy Asthma Immunol
; 93(6): 557-61, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15609765
Resultados
1 -
5
de 5
1
Próxima >
>>